Trials / Completed
CompletedNCT02152228
A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Entera Bio Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational, international, open label, pilot study to evaluate the safety, tolerability and efficacy of an oral PTH (1-34) preparation produced by Entera Bio in adult hypoparathyroid volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EnteraBio's Oral Parathyroid Hormone (1-34) | Oral administration |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2015-06-01
- Completion
- 2015-07-01
- First posted
- 2014-06-02
- Last updated
- 2015-10-07
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT02152228. Inclusion in this directory is not an endorsement.